Key result
Higher remnant cholesterol, history of COPD, higher Gensini scores, and monocytes were independent risk factors for in-stent restenosis after PCI.
Why the study?
An early predictive model incorporating medical history, angiographic characteristics, inflammatory indicators, and biochemical indices is urgently needed to predict in-stent restenosis events after PCI.
What are the independent risk factors for in-stent restenosis in CAD patients undergoing PCI with DES, and can they be used to build a predictive nomogram?
Cohort (n=477)
What are the independent risk factors for in-stent restenosis in CAD patients undergoing PCI with DES, and can they be used to build a predictive nomogram?
A novel nomogram incorporating remnant cholesterol, Gensini score, COPD history, and monocyte count can accurately predict the risk of in-stent restenosis after PCI with drug-eluting stents.
Answers are grounded in this paper and cite their sources.
Remnant cholesterol assessment should not yet change post-PCI practice; leaves open its role as a modifiable restenosis target.
Objective: In-stent restenosis (ISR) is a fatal complication of percutaneous coronary intervention (PCI). An early predictive model with the medical history of patients, angiographic characteristics, inflammatory indicators and blood biochemical index is urgently needed to predict ISR events. We aim to establish a risk prediction model for ISR in CAD patients undergoing PCI. Methods: A total of 477 CAD patients who underwent PCI with DES (drug-eluting stents) between January 2017 and December 2020 were retrospectively enrolled. And the preoperative factors were compared between the non-ISR and ISR groups. The least absolute shrinkage and selection operator (LASSO) and multi-factor logistic regression were used for statistical analysis. The prediction model was evaluated using receiver operator characteristic (ROC) analysis, the Hosmer-Lemeshow 2 statistic, and the calibration curve. Results: In this study, 94 patients developed ISR after PCI. Univariate analysis showed that post-PCI ISR was associated with the underlying disease (COPD), higher Gensini score (GS score), higher LDL-C, higher neutrophil/lymphocyte ratio, and higher remnant cholesterol (RC). The multi-factor logistic regression analysis suggested that remnant cholesterol (odds ratio [OR] = 2.09, 95% confidence interval [CI] [1.40-3.11], P < 0.001), GS score (OR = 1.01, 95% CI [1.00, 1.02], P = 0.002), medical history of COPD (OR = 4.56, 95% CI [1.98, 10.40], P < 0.001), and monocyte (OR = 1.30, 95% CI [1.04, 1.70], P < 0.001) were independent risk factors for ISR. A nomogram was generated and displayed favorable fitting (Hosmer-Lemeshow test P = 0.609), discrimination (area under ROC curve was 0.847), and clinical usefulness by decision curve analysis. Conclusion: Patients with certain preoperative characteristics, such as a history of COPD, higher GS scores, higher levels of RC, and monocytes, who undergo PCI may have a higher risk of developing ISR. The predictive nomogram, based on the above predictors, can be used to help identify patients who are at a higher risk of ISR early on, with a view to provide post-PCI health management for patients.
No takes yet. Share an insight, caveat, or question.
A 2022 study conducted a cohort in Coronary artery disease (CAD) undergoing PCI (n=477). Higher remnant cholesterol vs. Lower remnant cholesterol was evaluated on In-stent restenosis (ISR) (OR 2.09, 95% CI 1.40-3.11, p=<0.001). Higher remnant cholesterol, history of COPD, higher Gensini scores, and monocytes were independent risk factors for in-stent restenosis after PCI.
Synapse has enriched 10 related papers. Consider them for comparative context: